These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

211 related items for PubMed ID: 7846939

  • 1. [Sotalol and quinidine/verapamil (Cordichin) in chronic atrial fibrillation--conversion and 12-month follow-up--a randomized comparison].
    Kalusche D, Stockinger J, Betz P, Roskamm H.
    Z Kardiol; 1994; 83 Suppl 5():109-16. PubMed ID: 7846939
    [Abstract] [Full Text] [Related]

  • 2. Efficacy and proarrhythmic hazards of pharmacologic cardioversion of atrial fibrillation: prospective comparison of sotalol versus quinidine.
    Hohnloser SH, van de Loo A, Baedeker F.
    J Am Coll Cardiol; 1995 Oct; 26(4):852-8. PubMed ID: 7560608
    [Abstract] [Full Text] [Related]

  • 3. [Amiodarone and verapamil/quinidine in treatment of patients with chronic atrial fibrillation].
    Zehender M, Meinertz T, Just H.
    Z Kardiol; 1994 Oct; 83 Suppl 5():101-8. PubMed ID: 7846938
    [Abstract] [Full Text] [Related]

  • 4. [Conversion rate and prevention of recurrence of paroxysmal and sustained atrial fibrillation or atrial flutter with verapamil/quinidine].
    Trappe HJ, Pfitzner P.
    Med Klin (Munich); 1996 Oct 15; 91(10):617-25. PubMed ID: 9019638
    [Abstract] [Full Text] [Related]

  • 5. Atrial fibrillation: rate control often better than rhythm control.
    Prescrire Int; 2004 Apr 15; 13(70):64-9. PubMed ID: 15148984
    [Abstract] [Full Text] [Related]

  • 6. Suppression of paroxysmal atrial tachyarrhythmias--results of the SOPAT trial.
    Patten M, Maas R, Bauer P, Lüderitz B, Sonntag F, Dluzniewski M, Hatala R, Opolski G, Müller HW, Meinertz T, SOPAT Investigators.
    Eur Heart J; 2004 Aug 15; 25(16):1395-404. PubMed ID: 15321697
    [Abstract] [Full Text] [Related]

  • 7. [Treatment of atrial fibrillation in a Hungarian hospital department of cardiologic internal medicine at the turn of the millennium].
    Márk L, Erdej F, Dani G, Borbély M, Sziklai G, Nagy E, Hajdara I, Katona A.
    Orv Hetil; 2004 May 09; 145(19):1001-6. PubMed ID: 15181735
    [Abstract] [Full Text] [Related]

  • 8. Prevention of atrial fibrillation after cardioversion: results of the PAFAC trial.
    Fetsch T, Bauer P, Engberding R, Koch HP, Lukl J, Meinertz T, Oeff M, Seipel L, Trappe HJ, Treese N, Breithardt G, Prevention of Atrial Fibrillation after Cardioversion Investigators.
    Eur Heart J; 2004 Aug 09; 25(16):1385-94. PubMed ID: 15302102
    [Abstract] [Full Text] [Related]

  • 9. [Effects of amiodarone versus sotalol in treatment of atrial fibrillation: a random controlled clinical study].
    Niu F, Huang CX, Jiang H, Yang B, Guo WL, Chen YX, Jin CR, Liu ZM.
    Zhonghua Yi Xue Za Zhi; 2006 Jan 10; 86(2):121-3. PubMed ID: 16620720
    [Abstract] [Full Text] [Related]

  • 10. [Therapy of atrial fibrillation with class III anti-arrhythmia agents].
    Follath F, Candinas R, Frielingsdorf J.
    Herz; 1993 Feb 10; 18(1):20-6. PubMed ID: 8454249
    [Abstract] [Full Text] [Related]

  • 11. [Combination of quinidine and verapamil in auricular fibrillation].
    Sobrino JA, Maté I, Calvo L, Plaza I, Rico J, Moreno I, Mesa JM.
    Rev Esp Cardiol; 1989 Apr 10; 42(4):262-6. PubMed ID: 2781120
    [Abstract] [Full Text] [Related]

  • 12. Atrial fibrillation: what are the effects of drug therapy on the effectiveness and complications of electrical cardioversion?
    Sarubbi B, Ducceschi V, D'Andrea A, Liccardo B, Santangelo L, Iacono A.
    Can J Cardiol; 1998 Oct 10; 14(10):1267-73. PubMed ID: 9852940
    [Abstract] [Full Text] [Related]

  • 13. [Combination treatment of atrial arrhythmias with quinidine-verapamil].
    Gülker H, Bramann HU, Brisse B, Kuhs H.
    Med Klin; 1980 Feb 29; 75(5):196-8. PubMed ID: 6156393
    [Abstract] [Full Text] [Related]

  • 14. Maintenance of sinus rhythm after electrical cardioversion of persistent atrial fibrillation; sotalol vs bisoprolol.
    Plewan A, Lehmann G, Ndrepepa G, Schreieck J, Alt EU, Schömig A, Schmitt C.
    Eur Heart J; 2001 Aug 29; 22(16):1504-10. PubMed ID: 11482924
    [Abstract] [Full Text] [Related]

  • 15. [Medicamentous prevention after electric cardioversion of chronic atrial fibrillation. Goals and design of the PAFAC Study].
    Fetsch T, Burschel G, Breithardt G, Engberding R, Koch HP, Lukl J, Trappe HJ, Treese N.
    Z Kardiol; 1999 Mar 29; 88(3):195-207. PubMed ID: 10355070
    [Abstract] [Full Text] [Related]

  • 16. The effect of oral magnesium, alone or as an adjuvant to sotalol, after cardioversion in patients with persistent atrial fibrillation.
    Frick M, Darpö B, Ostergren J, Rosenqvist M.
    Eur Heart J; 2000 Jul 29; 21(14):1177-85. PubMed ID: 10924301
    [Abstract] [Full Text] [Related]

  • 17. Aggravation of postcardioversion atrial dysfunction by sotalol.
    Pollak A, Falk RH.
    J Am Coll Cardiol; 1995 Mar 01; 25(3):665-71. PubMed ID: 7860911
    [Abstract] [Full Text] [Related]

  • 18. Ibutilide in persistent atrial fibrillation refractory to conventional cardioversion methods.
    Naegeli B, Straumann E, Bertel O.
    Int J Cardiol; 2005 Mar 18; 99(2):283-7. PubMed ID: 15749188
    [Abstract] [Full Text] [Related]

  • 19. [Pharmacologic restoration of sinus rhythm in atrial flutter and fibrillation].
    Vainer J, Smíd J, Cepeláková H, Hapala J, Topinka I, Topolcan O.
    Vnitr Lek; 1989 Feb 18; 35(2):145-50. PubMed ID: 2711622
    [Abstract] [Full Text] [Related]

  • 20. A prospective, randomized controlled trial comparing the efficacy and safety of sotalol, amiodarone, and digoxin for the reversion of new-onset atrial fibrillation.
    Joseph AP, Ward MR.
    Ann Emerg Med; 2000 Jul 18; 36(1):1-9. PubMed ID: 10874228
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.